Friendly" labels on the packaging are becoming more common as a growing number of Americans try obesity drugs like Wegovy and ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

As California ends Medicaid coverage for GLP-1 weight loss drugs like Wegovy and Zepbound, experts say the state's advice to ...

Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...

A more detailed review of data by the FDA showed that GLP-1 drugs do not increase the risk of suicidal ideation or behavior.

So I wasn’t surprised when Williams was hit with a whole lot of “how dare you”—as Oprah Winfrey put it on the January 13 ...

Eli Lilly (NYSE: LLY) and Johnson & Johnson (NYSE: JNJ) both delivered strong third-quarter results, but their earnings ...

The past year was one of turbulence and change at Novo Nordisk, and, while the Danish drugmaker still has its work cut out ...

Oprah Winfrey says she had one big main side effect from taking a GLP-1 weight-loss drug. The most common problems for ...

While GLP-1s boast impressive weight loss results, making one mistake could result in the pounds coming right back on, ...

Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...